GP-Act III Acquisition Corp. $GPAT Holdings Decreased by Karpus Management Inc.

Karpus Management Inc. reduced its holdings in GP-Act III Acquisition Corp. (NASDAQ:GPAT) by 35.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,339,016 shares of the company’s stock after selling 1,269,161 shares during the period. Karpus Management Inc.’s holdings in GP-Act III Acquisition were worth $24,677,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of GPAT. Clear Street LLC increased its holdings in shares of GP-Act III Acquisition by 8,429.8% in the 2nd quarter. Clear Street LLC now owns 10,321 shares of the company’s stock valued at $109,000 after purchasing an additional 10,200 shares during the period. Wellspring Financial Advisors LLC boosted its holdings in shares of GP-Act III Acquisition by 17.8% during the second quarter. Wellspring Financial Advisors LLC now owns 21,200 shares of the company’s stock worth $224,000 after purchasing an additional 3,200 shares during the period. Mizuho Securities USA LLC acquired a new stake in shares of GP-Act III Acquisition during the first quarter worth approximately $303,000. JPMorgan Chase & Co. purchased a new position in GP-Act III Acquisition during the second quarter valued at approximately $2,377,000. Finally, OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in GP-Act III Acquisition in the 2nd quarter valued at approximately $2,638,000.

GP-Act III Acquisition Price Performance

Shares of GPAT stock opened at $10.66 on Friday. The stock’s 50 day simple moving average is $10.66 and its 200 day simple moving average is $10.60. GP-Act III Acquisition Corp. has a twelve month low of $10.13 and a twelve month high of $10.72.

GP-Act III Acquisition (NASDAQ:GPAT) last announced its quarterly earnings results on Thursday, November 13th. The company reported $0.09 EPS for the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

GP-Act III Acquisition Profile

GP-Act III Acquisition Corp. operates as a blank check company, which was created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on November 23, 2020 and is headquartered in New York, NY.